---
title: "SUPRAN BRYAN — Ownership Dossier"
canonical: https://whiteintel.dev/entity/46f51e79-b477-51bb-9c02-e6b6d8daaa8d
json: https://whiteintel.dev/api/public/dossier/46f51e79-b477-51bb-9c02-e6b6d8daaa8d
identifier: sec:0001511797
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SUPRAN BRYAN

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001511797`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/46f51e79-b477-51bb-9c02-e6b6d8daaa8d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/46f51e79-b477-51bb-9c02-e6b6d8daaa8d  

## Ownership & control

### Holdings / subsidiaries

- **ALNYLAM PHARMACEUTICALS, INC.** (officer) — https://whiteintel.dev/entity/4b418581-d371-5444-94c4-d4cbdecc07b2
- **Viatris Inc** (director) — https://whiteintel.dev/entity/75a2d115-b38e-503c-b009-fe4c4f308feb
- **ICAGEN INC** (director) — https://whiteintel.dev/entity/8bb5d6ec-5781-5fdd-9c3f-f7fb56b4f2c3
- **KING PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/b37e7f15-0600-57e3-a17b-8265aad2124f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SUPRAN BRYAN**. Human view: https://whiteintel.dev/entity/46f51e79-b477-51bb-9c02-e6b6d8daaa8d · Structured JSON: https://whiteintel.dev/api/public/dossier/46f51e79-b477-51bb-9c02-e6b6d8daaa8d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._